title: Prescribing in a pandemic: best use of oseltamivir in paediatric intensive care.
authors.forename: A C
authors.initials: AC
authors.lastname: Seale
authors.forename: F S
authors.initials: FS
authors.lastname: Toussaint
authors.forename: A
authors.initials: A
authors.lastname: Finn
authors.forename: J I
authors.initials: JI
authors.lastname: Fraser
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004363:Drug Utilization / Q000706:statistics & numerical data; D004739:England / Q000453:epidemiology; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification*; D007251:Influenza, Human / Q000188:drug therapy*; D015278:Intensive Care Units, Pediatric / Q000592:standards*; D008297:Male; D008485:Medical Audit; D053139:Oseltamivir / Q000627:therapeutic use*; D058873:Pandemics; D017410:Practice Guidelines as Topic; D055553:Prescription Drugs / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D055553:Prescription Drugs; D053139:Oseltamivir